Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Scioto Biosciences
company
About
Scioto is a developer of Activated Bacterial Therapeutics platform.
- 51 - 100
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $330K
- Industries
- Biotechnology,Diabetes,Health Care,Life Science,Therapeutics
- Founded date
- Jan 1, 2017
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Scioto Biosciences is a developer of Activated Bacterial Therapeutics (ABT) platform intended to deliver live bacteria to the gut. The company is developing innovative therapies devoted to having a transformative impact on the delivery of microbiome therapeutics, enabling medical practitioners to advance healing through microbiome therapeutics.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$2.63M
Scioto Biosciences has raised a total of
$2.63M
in funding over 2 rounds. Their latest funding was raised on
Aug 22, 2019 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 22, 2019 | Grant | $2.30M | 1 |
National Institutes of Health
|
— | Detail |
| May 1, 2017 | Grant | $330K | 1 |
National Institutes of Health
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
1
Scioto Biosciences is funded by 1 investors.
National Institutes of Health
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Institutes of Health
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
